Sari Hopson

Director, Epidemiology Strategy
Bristol Myers Squibb

Poster(s):

• (A-031) Patient-reported adverse events and subjective severity and impact among patients diagnosed with non-small cell lung cancer (NSCLC), renal cell cancer (RCC), colorectal cancer (CRC), and metastatic melanoma
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET